200 related articles for article (PubMed ID: 23184915)
1. Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer.
Sun L; Chen L; Sun L; Pan J; Yu L; Han L; Yang Z; Luo Y; Ran Y
Mol Cell Proteomics; 2013 Feb; 12(2):395-406. PubMed ID: 23184915
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of Mac-2 binding protein by hTERT in gastric cancer.
Park YP; Choi SC; Kim JH; Song EY; Kim JW; Yoon DY; Yeom YI; Lim JS; Kim JW; Paik SG; Lee HG
Int J Cancer; 2007 Feb; 120(4):813-20. PubMed ID: 17131321
[TBL] [Abstract][Full Text] [Related]
3. Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis.
Maekawa T; Kamada Y; Ebisutani Y; Ueda M; Hata T; Kawamoto K; Takamatsu S; Mizutani K; Shimomura M; Sobajima T; Fujii H; Nakayama K; Nishino K; Yamada M; Kumada T; Ito T; Eguchi H; Nagano H; Miyoshi E
World J Gastroenterol; 2016 May; 22(17):4403-10. PubMed ID: 27158210
[TBL] [Abstract][Full Text] [Related]
4. Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes.
Srirajaskanthan R; Caplin ME; Waugh MG; Watkins J; Meyer T; Hsuan JJ; Beaumont NJ
Mol Cell Proteomics; 2010 Apr; 9(4):656-66. PubMed ID: 20019050
[TBL] [Abstract][Full Text] [Related]
5. Antibody library-based tumor endothelial cells surface proteomic functional screen reveals migration-stimulating factor as an anti-angiogenic target.
Hu H; Ran Y; Zhang Y; Zhou Z; Harris SJ; Yu L; Sun L; Pan J; Liu J; Lou J; Yang Z
Mol Cell Proteomics; 2009 Apr; 8(4):816-26. PubMed ID: 19117829
[TBL] [Abstract][Full Text] [Related]
6. Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells.
Shirure VS; Reynolds NM; Burdick MM
PLoS One; 2012; 7(9):e44529. PubMed ID: 22970241
[TBL] [Abstract][Full Text] [Related]
7. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
8. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel 70K Mac-2 binding protein antibody through screening of fucosylation-related antibodies.
Masuda M; Asuka T; Terao N; Nishino S; Ikeda S; Takamatsu S; Kondo J; Miyoshi E
J Biochem; 2023 May; 173(6):487-495. PubMed ID: 36760066
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas.
Nonaka M; Ma BY; Imaeda H; Kawabe K; Kawasaki N; Hodohara K; Kawasaki N; Andoh A; Fujiyama Y; Kawasaki T
J Biol Chem; 2011 Jun; 286(25):22403-13. PubMed ID: 21515679
[TBL] [Abstract][Full Text] [Related]
11. Role of STAT3 as a negative regulator in Mac2- binding protein expression.
Park YP; Kim JT; Yang Y; Lim JS; Yoon DY; Kim JW; Lee HG
Korean J Lab Med; 2008 Jun; 28(3):230-8. PubMed ID: 18594176
[TBL] [Abstract][Full Text] [Related]
12. Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer.
Yao G; Tang J; Yang X; Zhao Y; Zhou R; Meng R; Zhang S; Dong X; Zhang T; Yang K; Wu G; Xu S
Theranostics; 2020; 10(24):11144-11158. PubMed ID: 33042275
[No Abstract] [Full Text] [Related]
13. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
14. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.
Cheng L; Yang Q; Li C; Dai L; Yang Y; Wang Q; Ding Y; Zhang J; Liu L; Zhang S; Fan P; Hu X; Xiang R; Yu D; Wei Y; Deng H
J Cell Mol Med; 2017 Aug; 21(8):1532-1544. PubMed ID: 28211159
[TBL] [Abstract][Full Text] [Related]
15. NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas.
Yang Q; Ou C; Liu M; Xiao W; Wen C; Sun F
Carcinogenesis; 2014 Jul; 35(7):1643-51. PubMed ID: 24710624
[TBL] [Abstract][Full Text] [Related]
16. Serum Mac-2BP does not distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasia.
Peehl DM; Chen Z; Nolley R
Prostate; 2011 Jan; 71(1):26-31. PubMed ID: 20583127
[TBL] [Abstract][Full Text] [Related]
17. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers.
Kikuchi T; Hassanein M; Amann JM; Liu Q; Slebos RJ; Rahman SM; Kaufman JM; Zhang X; Hoeksema MD; Harris BK; Li M; Shyr Y; Gonzalez AL; Zimmerman LJ; Liebler DC; Massion PP; Carbone DP
Mol Cell Proteomics; 2012 Oct; 11(10):916-32. PubMed ID: 22761400
[TBL] [Abstract][Full Text] [Related]
18. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
[TBL] [Abstract][Full Text] [Related]
19. Induction of Mac-2BP by nerve growth factor is regulated by the PI3K/Akt/NF-kappaB-dependent pathway in the HEK293 cell line.
Park YP; Choi SC; Kim BY; Kim JT; Song EY; Kang SH; Yoon DY; Paik SG; Kim KD; Kim JW; Lee HG
BMB Rep; 2008 Nov; 41(11):784-9. PubMed ID: 19017490
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
